FDA describes plans to expand remote regulatory assessments

Regulatory News

Regulatory NewsJoanne S. Eglovitch

APIsAudit/inspectionBiotechnologyComplianceDiagnostics/IVDsMedical DevicesNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy